Nanoviricides Inc (NNVC)
1.89
+0.06
(+3.28%)
USD |
NYAM |
May 10, 16:00
1.88
-0.01
(-0.53%)
After-Hours: 20:00
Nanoviricides Max Drawdown (5Y): 97.68% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.68% |
March 31, 2024 | 97.68% |
February 29, 2024 | 97.68% |
January 31, 2024 | 97.68% |
December 31, 2023 | 97.68% |
November 30, 2023 | 97.68% |
October 31, 2023 | 97.68% |
September 30, 2023 | 97.68% |
August 31, 2023 | 97.68% |
July 31, 2023 | 97.68% |
June 30, 2023 | 97.68% |
May 31, 2023 | 97.68% |
April 30, 2023 | 97.68% |
March 31, 2023 | 97.68% |
February 28, 2023 | 97.68% |
January 31, 2023 | 97.68% |
December 31, 2022 | 97.68% |
November 30, 2022 | 97.68% |
October 31, 2022 | 97.68% |
September 30, 2022 | 97.68% |
August 31, 2022 | 97.68% |
July 31, 2022 | 97.68% |
June 30, 2022 | 97.68% |
May 31, 2022 | 97.68% |
April 30, 2022 | 97.68% |
Date | Value |
---|---|
March 31, 2022 | 97.68% |
February 28, 2022 | 97.68% |
January 31, 2022 | 97.68% |
December 31, 2021 | 97.68% |
November 30, 2021 | 97.68% |
October 31, 2021 | 97.68% |
September 30, 2021 | 97.68% |
August 31, 2021 | 97.68% |
July 31, 2021 | 97.68% |
June 30, 2021 | 97.68% |
May 31, 2021 | 97.68% |
April 30, 2021 | 97.68% |
March 31, 2021 | 97.68% |
February 28, 2021 | 97.68% |
January 31, 2021 | 97.68% |
December 31, 2020 | 97.68% |
November 30, 2020 | 97.68% |
October 31, 2020 | 97.68% |
September 30, 2020 | 97.68% |
August 31, 2020 | 97.68% |
July 31, 2020 | 97.68% |
June 30, 2020 | 97.68% |
May 31, 2020 | 97.68% |
April 30, 2020 | 97.68% |
March 31, 2020 | 97.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.77%
Minimum
May 2019
97.68%
Maximum
Oct 2019
97.54%
Average
97.68%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
EyePoint Pharmaceuticals Inc | 93.95% |
Enanta Pharmaceuticals Inc | 92.26% |
GlycoMimetics Inc | 97.87% |
FibroGen Inc | 99.37% |
Corvus Pharmaceuticals Inc | 95.28% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -34.74 |
Beta (5Y) | 0.6978 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 131.2% |
Historical Sharpe Ratio (5Y) | -0.2055 |
Historical Sortino (5Y) | -0.6221 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.41% |